4
Changes in Ownership
ARROWHEAD PHARMACEUTICALS, INC. Filed Acc 0001628280-24-010062
Chief Financial Officer sold 40,000 shares at $35.19 ($1,407,600)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Myszkowski Kenneth Allen Chief Financial Officer | 2024-03-06 | Sale | −40,000 | $35.19 | $1,407,600 | 400,600 | D |
| Open-market sales · 40,000 sh · avg $35.19 · $1,407,600 | |||||||
Loading xslF345X05/wk-form4_1709938483.xml…